American Bio Medica (ABMC) Osake Kurssi
American Bio Medica Kurssi
American Bio Medican liikevaihto on supistunut 12,9 % vuodessa viimeisten 19 vuoden aikana 913 000,00 USD:een. Osakekohtainen tulos on laskenut 42,4 % vuodessa viimeisten 3 vuoden aikana. American Bio Medican nettomarginaali on nyt −154,4 %, laskenut −26,5 %:sta muutama vuosi sitten.
American Bio Medica osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
American Bio Medica liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset American Bio Medica -osakkeesta
American Bio Medica Corp is a pharmaceutical company that specializes in developing and manufacturing diagnostic tests for drug abuse. Their business model revolves around producing reliable, accurate, and cost-effective test kits that detect drug usage. With a focus on innovation and quality, American Bio Medica Corp aims to provide healthcare professionals and organizations with effective tools to identify and prevent substance abuse. Through their dedication to research and development, they strive to improve public health and safety by offering advanced diagnostic solutions in the field of drug testing.
American Bio Medica Corp is primarily active in the healthcare and diagnostic industries.
The main competitors of American Bio Medica Corp in the market include companies such as Abbott Laboratories, Alere Inc., and Thermo Fisher Scientific.
American Bio Medica Corp is a leading provider of diagnostic testing solutions. Founded in 1984, the company specializes in the development, manufacturing, and marketing of immunoassay tests for drugs of abuse. With a commitment to accuracy and reliability, American Bio Medica Corp has built a strong reputation for its high-quality products and cutting-edge technology. The company's extensive product portfolio includes tests for drugs such as cocaine, marijuana, amphetamines, and opioids. With years of experience in the industry, American Bio Medica Corp continues to innovate and deliver solutions that meet the evolving needs of healthcare professionals and organizations worldwide.
American Bio Medica Corp has achieved several significant milestones throughout its history. Some of these notable accomplishments include the development of innovative drug testing solutions, earning certifications and regulatory approvals for their products, and establishing strategic partnerships with industry leaders. The company has successfully expanded its product portfolio, offering a comprehensive range of rapid drug testing kits and laboratory services. American Bio Medica Corp has also demonstrated its commitment to research and development, continuously improving its technologies to meet evolving market demands. With its dedication to quality and innovation, American Bio Medica Corp maintains its position as a leading provider of drug testing solutions in the industry.
American Bio Medica Corp is primarily present in the United States.
American Bio Medica Corp represents values of innovation, quality, and commitment to public health. The company strives to develop and produce cutting-edge diagnostic products and healthcare solutions that improve patients' lives. American Bio Medica Corp places great emphasis on delivering accurate and reliable testing solutions to various healthcare providers, enabling them to make informed decisions for their patients. The company's corporate philosophy is centered around providing excellent customer service, fostering strong partnerships, and continuously advancing its technologies to meet the evolving needs of the medical industry. American Bio Medica Corp is dedicated to making a positive impact on global healthcare outcomes through its products and services.
American Bio Medica Corporation is a leading global provider of point-of-care drug and alcohol tests, as well as services related to the drug and alcohol screening industry. The company has been in business since 1986 and is headquartered in Kinderhook, New York. One of the company's main areas of focus is the development, manufacturing, and distribution of drug and alcohol tests used in the healthcare industry, criminal justice system, workplace testing, and military population. The company's tests are fast and reliable, delivering results within minutes. They are available in various formats, including urine and saliva tests, and adhere to the highest quality and safety standards. Another key segment of American Bio Medica Corporation is the workplace drug testing market. The company offers a variety of tests and services to help employers implement successful drug screening programs. In addition to providing the necessary tests, the company also offers training, support, and consulting services to help businesses effectively implement their testing programs. In addition to the workplace drug testing market, American Bio Medica Corporation is also involved in the criminal justice sector. The company offers products and services that can be used for drug screening of individuals in the criminal justice system. These tests can help ensure compliance with probation requirements and ensure that individuals struggling with drug problems receive the appropriate help. Another important area for the company is the use of drug tests in healthcare. American Bio Medica Corporation provides a variety of tests that can be used by physicians, clinics, and other medical professionals for quick and reliable diagnosis of certain diseases and conditions. In addition to its core business areas, American Bio Medica Corporation also offers services such as training and consulting. The company has a team of experts who can assist customers in improving and optimizing their drug and alcohol screening programs. In summary, American Bio Medica Corporation specializes in the development, manufacturing, and distribution of drug and alcohol tests, as well as related services. The company serves a variety of industries, including workplace testing, criminal justice, and healthcare, offering a wide range of reliable and fast tests that adhere to the highest quality and safety standards. American Bio Medica Corporation is committed to providing its customers with excellent service and support, as well as innovative solutions to enhance their drug and alcohol screening programs.
Liikevaihtoa ei voida laskea American Bio Medica:lle tällä hetkellä.
Voittoa ei voida laskea American Bio Medica:lle tällä hetkellä.
P/E-suhdetta ei voida laskea American Bio Medica:lle tällä hetkellä.
P/S-suhdetta ei voida laskea American Bio Medica:lle tällä hetkellä.
American Bio Medica:n Eulpool-laatuscore on 4/10.
American Bio Medica:n ISIN on US0246001087. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
American Bio Medica:n WKN on 912562. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
American Bio Medica:n ticker on ABMC. Tämä pörssinoteeraus käytetään American Bio Medica-osakkeiden kauppaan pörssissä.
American Bio Medica osake
American Bio Medica vertaisryhmä
American Bio Medica Ticker
American Bio Medica FIGI
Kaikki tunnusluvut ja syvällinen analyysi American Bio Medica:sta
Meidän osakeanalyysimme American Bio Medica-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut American Bio Medica:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: